background
rapid
diagnost
test
rdt
infecti
diseas
turnaround
time
hour
promis
tool
could
improv
patient
care
antimicrobi
stewardship
infect
prevent
emerg
depart
ed
set
numer
rdt
develop
necessarili
ed
environ
success
implement
ed
reli
perform
impact
patient
manag
object
aim
narr
review
provid
overview
current
avail
rdt
infecti
diseas
ed
sourc
pubm
search
august
avail
studi
rdt
infecti
diseas
inclus
criteria
includ
commerci
test
approv
fda
ivd
data
clinic
sampl
abil
run
fullyautom
system
result
deliveri
within
hour
content
nonexhaust
list
repres
commerci
avail
fda
ce
approv
assay
categor
clinic
syndrom
pharyng
upper
respiratori
tract
infect
lower
respiratori
tract
infect
gastrointestin
infect
mening
enceph
fever
return
travel
sexuallytransmit
infect
includ
hiv
perform
test
describ
base
clinic
valid
studi
impact
clinic
outcom
antiinfect
use
discuss
focu
edbas
studi
implic
clinician
familiar
distinct
featur
rdt
individu
perform
characterist
target
integr
ed
workflow
preplan
consid
local
constraint
given
set
addit
clinic
studi
need
evalu
clinic
cost
effect
pierc
vm
elkan
leet
mcgowan
kl
hodinka
rl
comparison
idaho
technolog
filmarray
system
realtim
pcr
detect
respiratori
pathogen
children
j
clin
microbiol
loeffelholz
mj
pong
dl
pyle
rb
xiong
miller
al
bufton
kk
et
al
comparison
filmarray
respiratori
panel
prodess
realtim
pcr
assay
detect
respiratori
pathogen
j
clin
nasopharyng
swab
j
clin
microbiol
pancholi
p
kelli
c
raczkowski
baladallasat
jm
detect
toxigen
clostridium
difficil
comparison
cell
cultur
neutral
xpert
c
difficil
xpert
c
difficileepi
illumigen
c
difficil
assay
j
clin
microbiol
legionella
fia
binaxnow
r
legionella
urinari
antigen
card
two
nation
refer
center
eur
j
clin
microbiol
infect
di
sinclair
xie
x
teltscher
dendukuri
n
systemat
review
metaanalysi
urinebas
pneumococc
antigen
test
diagnosi
communityacquir
pneumonia
caus
streptococcu
pneumonia
j
clin
microbiol
matta
day
n
lescat
hoi
ab
varon
e
gutmann
l
mainardi
jl
clinician
consid
result
binaxnow
streptococcu
pneumonia
urinari
antigen
test
adapt
antibiot
regimen
pneumonia
patient
clin
microbiol
infect
schimmel
jj
haessler
imrey
p
lindenau
pk
richter
ss
yu
pc
rothberg
mb
pneumococc
urinari
antigen
test
us
hospit
miss
opportun
antimicrobi
stewardship
clin
infect
di
pii
rapid
diagnost
test
rdt
infecti
diseas
recent
implement
mani
laboratori
emerg
depart
ed
goal
expedit
diagnosi
infecti
diseas
infect
prevent
appropri
initi
manag
facilit
antimicrobi
stewardship
ed
rapid
clinic
decis
must
undertaken
context
overcrowd
time
pressur
even
though
multipl
rdt
current
avail
success
implement
ed
requir
care
assess
perform
characterist
potenti
benefit
patient
care
cost
consider
well
wellorgan
implement
plan
optim
impact
goal
narr
review
provid
overview
current
avail
rdt
infecti
diseas
ed
detail
descript
perform
discuss
impact
patient
care
rdt
infecti
diseas
ed
depart
use
follow
mesh
keyword
virus
atyp
bacteria
bordetella
pertussi
bordetella
parapertussi
chlamydophila
pneumonia
mycoplasma
pneumonia
analyt
perform
characterist
compar
refer
pcr
assay
good
excel
sensit
specif
target
note
bacteri
target
valid
fewer
posit
sampl
perform
characterist
bacteri
pcr
sometim
report
lower
viral
pcr
highlight
need
caution
interpret
cumul
perform
result
furthermor
perform
panel
perform
assay
describ
specif
accord
publish
clinic
valid
studi
avail
absenc
test
comparison
gold
standard
assay
report
posit
neg
percent
agreement
clinic
studi
review
report
avoid
misinterpret
reader
sensit
extract
acut
infect
popul
specif
extract
individu
popul
describ
correspond
refer
